Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_assertion type Assertion NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_head.
- NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_assertion description "[The +936C allele, which is also hypothesized to increase VEGF expression, was not clearly associated with invasive breast cancer (OR 1.21, 95% CI 0.88-1.67 for +936 CC versus TT/CT), but it was associated with reduced risk for in situ cancer (OR 0.59, 95% CI 0.37-0.93 for CC versus TT/CT).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_provenance.
- NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_assertion evidence source_evidence_literature NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_provenance.
- NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_assertion SIO_000772 16613616 NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_provenance.
- NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_assertion wasDerivedFrom befree-20140225 NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_provenance.
- NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_assertion wasGeneratedBy ECO_0000203 NP386071.RAjDxc62B-qWWceDPmzGK3g_Adb3iIlYOcA7Nc-549k9w130_provenance.